Day

May 19, 2017
This review discusses pre-clinical and clinical studies on the use of monoclonal antibodies in multiple myeloma, including agents which have been shown to have no activity against myeloma cells. It outlines various agents and their specific targets, focusing particularly on those agents with strong evidence in clinical trials. This review highlights the benefits of immunotherapy...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand